Academic Journal

251P Real-world clinical outcomes of palbociclib plus endocrine therapy (ET) in hormone receptor–positive advanced breast cancer: Results from the POLARIS trial

التفاصيل البيبلوغرافية
العنوان: 251P Real-world clinical outcomes of palbociclib plus endocrine therapy (ET) in hormone receptor–positive advanced breast cancer: Results from the POLARIS trial
المؤلفون: Tripathy, D., Rocque, G., Blum, J.L., Karuturi, M.S., McCune, S., Kurian, S., Moezi, M.M., Anderson, D., Gauthier, E., Zhang, Z., Montelongo, M., Wang, Y.
المصدر: Annals of Oncology ; volume 33, page S651-S652 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.annonc.2022.07.290
الاتاحة: http://dx.doi.org/10.1016/j.annonc.2022.07.290
https://api.elsevier.com/content/article/PII:S092375342202141X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S092375342202141X?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.9FF0D1B9
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.annonc.2022.07.290